Company
United StatesAxolotl Biologix, Inc., Flagstaff, AZ – FDA Inspections
Inspection records and compliance data for Axolotl Biologix, Inc. in Flagstaff, Arizona. 2 FDA inspections on record, last inspected September 29, 2022.
Company Profile
This profile covers Axolotl Biologix, Inc. based in Flagstaff, Arizona, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected August 4, 2017. Last inspected September 29, 2022.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 29, 2022 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1181263 |
| August 4, 2017 | NAI | Biologics · Blood and Blood Products | 1026690 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Axolotl Biologix, Inc.
FEI Number
3012345793
Address
2201 N Gemini Dr Ste 140, Flagstaff, Arizona 86001, United States
Country
United States
ID: 3ba40e89-e411-499e-ad79-3e54d1d2e8ae